hsa for tirzepatide LifeMD Understanding HSA & FSA Eligibility

Patients are finally experiencing meaningful appetite control and, in many cases, significant weight loss

We noted that cumulatively applied retatrutide starting at 10 nM (up to 100 nM the highest concentration tested) elevated FOC in HAP in a concentration- and time-dependent manner

INTRODUCTION TO SEMAGLUTIDE Semaglutide has been one of our most frequently asked-about treatments

Clinically proven to help patients lose up to 15% of their body weight

In patients with obesity (mean age 51.3 years, 65.6% women), semaglutide compared with non-GLP-1RA anti-obesity medications was associated with lower risk for incident CUD in patients with no prior history CUD (HR: 0.56, 95% CI: 0.420.75), and recurrent CUD diagnosis in patients with a prior history CUD (HR: 0.62, 95% CI: 0.460.84)

Consumers engaging with GLP-1 medications may also be making lifestyle changes and taking supplements to manage their needs